The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

Radiation oncology is being rapidly reshaped by advances in imaging, artificial intelligence, and our understanding of the tumor microenvironment. Over the ...

Nuclear medicine is a rapidly evolving domain at the intersection of advanced radiopharmaceuticals, hybrid imaging modalities such as PET/CT and PET/MR, and ...